CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Interferon beta-1a

Last Updated: March 8, 2013
Result type: Reports
Project Number: SR0298-000
Product Line: Reimbursement Review

Generic Name: Interferon beta-1a

Brand Name: Rebif

Manufacturer: EMD Serono

Therapeutic Area: Clinically isolated syndrome

Indications: Clinically Isolated Syndrome

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: August 15, 2013

Recommendation Type: Do not list